patient outcome improvement News
-
Baymatob™ takes home three major MDCTP prizes
BaymatobTM was awarded three major prizes at the 2017 Medical Device Commercialisation Training Program (MDCTP) showcase evening. CEO Sarah McDonald received the $50K IDE Group Design and Entrepreneurship Award, the $10K Davies Collins Cave IP Strategy Award, and the Cicada Innovations Incubation Award. The MDCTP is a NSW Health program run by Cicada Innovation with a commitment to build ...
-
Health Economics Outcomes evaluation of Stago D-dimer
Improved patient outcomes and experience, shorter length of stay and cost effectiveness drive the recognition of value in today’s rapidly-evolving and competitive healthcare environment. Stago contracted with Alira Health to conduct an economic evaluation comparing the use of the STA-Liatest D-Di assay to other D-dimer assays in conjunction with a probability assessment model for exclusion ...
-
Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference
Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that members of management will present at the upcoming H.C. Wainwright Bioconnect Virtual Conference. A Pre-recorded presentation will be available on Monday, January 10th ...
-
Shockwave Medical to Participate in Two Upcoming Investor Conferences
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating in two upcoming virtual investor conferences: The 2022 Wells Fargo Healthcare Conference Fireside Chat on Thursday, September 8, 2022, at 9:45 a.m. Eastern Time. The Morgan Stanley ...
-
Chief Medical Officer and Co-founder Dr. Sam Browd featured in Orthoworld
Proprio Chief Medical Officer & Co-founder Dr. Sam Browd was recently featured in Orthoworld’s “Orthopedics Collecting and Parsing Data in New Ways Via AI” article. Why is AI needed in the orthopedic O.R.? Dr. Browd: The application of artificial intelligence in a clinical setting creates an increased capability to amalgamate highly complex, multidimensional ...
-
Coremap Completes $10.5 Million Series A Financing
CoreMap announced today it has completed a $10.5 million Series A financing led by Qure Ventures. The round included both existing investors such as Ronny Ginor, MD of Fifth Focus/HRMG Investments and Orbimed Venture Partners, and a diverse group of new strategic, corporate and financial partners. CoreMap was founded in 2016 by Dr. Peter Spector and based on his groundbreaking work concerning the ...
By CoreMap Inc.
-
Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference
Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the Company will participate in the upcoming 42nd Annual Cowen Health Care Conference. Date: Wednesday, March 9, 2022 Format: Fireside chat and 1×1 meetings The ...
-
Haymarket Medical Education/myCME Earns Independent Certification
Haymarket Medical Education (HME)/myCME, a global leader in continuing medical education (CME), announced it has achieved independent certification for conformance to industry-established information security management guidelines and the BPA Worldwide standards for audience qualification, measurement and reporting from BPA Worldwide’s iCompli Technology Assurance division. HME/myCME ...
-
Case Study: Realists Training Technologies GmbH
Realists GmbH is a global provider of lifelike surgical training systems to improve patient outcomes in the field of spinal surgery. Realists has integrated the NDI Polaris Vicra into their Realists Imaging product to simulate X-ray imaging for the navigation and placement of pedicle screws or cages, as in a real operation. Statement from Dr. Luis Bernal, CEO and Founder of Realists Training ...
-
Chief Medical Officer and Co-founder Dr. Sam Browd says `Data must enable surgeon performance`
Proprio Chief Medical Officer & Co-founder Dr. Sam Browd was recently mentioned in Orthoworld’s “Orthopedic Enabling Technology Startups Focused on Value” article. “Data is everywhere inside the operating room but has been severely underutilized. We have a huge opportunity to capture it, segment it into strategically informed action and ultimately improve patient ...
-
Correcting and Replacing: Shockwave Medical to Participate in Two Upcoming Investor Conferences
In a release issued under the same headline on August 26, 2022, by Shockwave Medical, Inc. (NASDAQ: SWAV), please note that the fireside chat time for the Wells Fargo Healthcare Conference has been updated. The correct presentation time is 9:10 am Eastern Time. The details for the Morgan Stanley Healthcare Conference remain the same. The corrected release appears below: Shockwave Medical, Inc. ...
-
electroCore to Participate at Canaccord Genuity MedTech and Diagnostics and Digital Health & Services Forum
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will be conducting one-on-ones at the Canaccord Genuity MedTech and Diagnostics and Digital Health & Services Forum. Canaccord Genuity MedTech and Diagnostics and Digital Health & Services Forum Date: Thursday, November ...
-
Noah Medical Presents Data, Showcases the Galaxy System at CHEST Annual Meeting
Medical robotics innovator Noah Medical provided physicians attending the American College of Chest Physicians 2022 meeting with a preview of study data documenting its high tool in lesion rate. This data subset and demonstrations of the Galaxy System were met with excellent reviews from the interventional pulmonology community. The Galaxy System is designed to provide a fully integrated ...
By Noah Medical
-
BIO’s Dr. McMurry-Heath Says Racism a `Chronic Disease` Plaguing Society
In the wake of tragic deaths and civil unrest, BIO’s President and CEO Dr. Michelle McMurry-Heath announced she will lead a panel discussion next week at BIO Digital with industry leaders on the state of race and equity within the biotechnology industry. Following the announcement, Dr. McMurry-Heath shared her thoughts on events that have taken place in recent days: “To say our ...
-
MediPurpose Awarded Vizient Contract for SurgiLance Safety Lancets
MediPurpose announced today that it has signed an agreement with Vizient to offer SurgiLance™ Safety Lancets to all Vizient members at contracted pricing. Vizient is the largest member-driven healthcare performance improvement company in the US, providing solutions and services that improve the delivery of high-value care by aligning cost, quality and market performance for more than 50% ...
By MediPurpose
-
Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis
BOSTON – June 22, 2022 – Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing round. The round was led by an undisclosed strategic investor, with participation from Biovision Ventures, a new Europe-based fund, and existing investors, including MedTex ...
By Elucid
-
Elucid announces American Medical Association (AMA) instates CPT Code for Lipid-Rich Necrotic Core Quantification to Assess Atherosclerotic Plaque Stability
BOSTON – December 17, 2021 – Elucid, a Boston-based medical technology company harnessing scientific imaging and artificial intelligence to enable the precise diagnosis and treatment of the world’s leading cause of death announced a new CPT code unique to its Plaque IQ technology for CT angiography. Plaque composition, specifically lipid-rich necrotic core, has been identified ...
By Elucid
-
Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers
BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced that first author and Elucid founder Andrew Buckler presented findings today from the EVAPORATE (Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking ...
By Elucid
-
Eyevensys Announces the First-in-Human Treatment with its GroundBreaking EyeCET ElectroTransfection Technology for Eye Diseases
Eyevensys announces today that it has successfully treated the first patient in a first-in-human phase I/II trial of its lead candidate EYS606 for Non-Infectious Uveitis (NIU). The patient was treated in Paris, France at the Cochin Institute by Professor Antoine Brézin, the principal investigator of the trial, using the company’s novel EyeCET technology. EYS606 is the ...
By Eyevensys
-
Planmeca and Navigate Surgical Technologies Join Forces to Launch Innovative Solutions for Dental Im
Dental manufacturer Planmeca and Navigate Surgical Technologies (NST), a provider of real-time surgical navigation solutions, are pleased to announce their cooperation. This partnership aims to provide dental implant surgeons with technological innovations that will deliver enhanced patient outcomes through improved accuracy and precision, as well as through simplified digital workflows. Dynamic ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you